Innate Pharma
(IPHYF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 06-2014 | 12-2013 | 06-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,450 | 101,470 | 50,950 | 29,710 | 39,330 |
| Marketable Securities | 6,580 | 6,780 | 3,970 | 2,590 | 2,610 |
| Receivables | 13,390 | 16,520 | 10,620 | 13,580 | 10,770 |
| Other current assets | 10 | 0 | 10 | 10 | 10 |
| TOTAL | $105,430 | $124,770 | $65,550 | $45,890 | $52,720 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 130 | 360 | 180 | 610 |
| Other Non-Current Assets | 7,230 | 8,708 | 8,313 | 8,530 | 8,770 |
| TOTAL | $7,230 | $8,838 | $8,673 | $8,710 | $9,380 |
| Total Assets | $120,550 | $141,930 | $74,220 | $54,610 | $62,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,720 | 16,860 | 11,500 | 18,000 | 18,240 |
| Other current liabilities | 600 | N/A | 0 | N/A | 0 |
| TOTAL | $14,320 | $17,460 | $12,320 | $19,520 | $19,750 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,030 | 2,370 | 2,800 | 4,030 | 8,020 |
| TOTAL | $7,030 | $7,830 | $8,380 | $7,020 | $12,290 |
| Total Liabilities | $21,350 | $25,300 | $20,710 | $26,550 | $32,060 |
| Shareholders' Equity | |||||
| Common Shares | 3,510 | 3,630 | 3,030 | 2,490 | 2,430 |
| Retained earnings | -119,470 | -123,410 | -119,490 | -116,730 | -111,970 |
| Other shareholders' equity | -26,430 | -12,480 | -50 | -40 | -20 |
| TOTAL | $99,200 | $116,630 | $53,510 | $28,050 | $30,040 |
| Total Liabilities And Equity | $120,550 | $141,930 | $74,220 | $54,600 | $62,100 |